Asia Pacific Medical Technology Development Company Limited

The company specializes in centrifugal pump drive units, specifically designed for cardiopulmonary bypass systems. These devices, like the Anivia SG1000 Pump Console, are used to support extracorporeal circulation during surgeries requiring heart-lung bypass.

The company is headquartered in the United States. While its name suggests an Asia Pacific focus, its operational base and regulatory filings are tied to the US market.

The company’s centrifugal pump drive units, such as the Anivia SG1000 Pump Console, are included in the FDA’s Unique Device Identifier (UDI) database. This registry tracks Class II devices authorized for commercial distribution in the US.

The company’s centrifugal pump drive units fall under FDA Class II classification. This category applies to devices that pose moderate risk and require special controls beyond general controls to ensure safety and effectiveness.